Astragalus herb is used by Chinese doctors to stimulate the immune system and to improve cardiovascular health. This plant is native to Northern China and Mongolia and inhabits mostly pine forests and sandy soils. Chinese doctors have used astragalus herb to fight the common cold and the flu.
Human studies
Only a few
human studies have been published with astragalus root
and extract.
Products on the market, in health food
stores and onlinedf
There are dozens of astragalus products available without a prescription.
Astragalus (root) 300 mg per capsule
Astragalus (Astragalus membranaceus) (root) 470 mg
Astragalus root herb extract - 500 mg (standardized to 0.4% methoxyisoflavones).
The web site where this product can be purchased has a reliable history of being
honest and providing good service to its customers.
Astragalus Root (high grade) - 500 mg
Astragalus Root (Astragalus membranaceus) 500 mg
Liquid
Astragalus membranaceus (Huang Ch'i) - Certified organic grain alcohol (42-46%),
distilled water and Astagalus extractives.
Composition
of astragalus root
Astragalus root has polysaccharides that have a role in
influencing the immune system. Astragalus root also contains saponins called
astragalosides
and astramembranosides, along with flavonoids and triterpenes.
Three major
flavonoids are ononin, formononetin, and demethylhomopterocarpin.
Benefits of Astragalus extract
Aplastic anemia
Clinical study on effect of Astragalus Injection and
its immuno-regulation action in treating chronic aplastic anemia.
Chin J Integr Med. 2007 June. TCM Hospital of Langfang City, Chinese
Hemopathic Therapeutic Center of TCM, Hebei, 065000, China.
Sixty patients with aplastic anemia were randomly assigned to
two groups equally, both were treated with Stanozolol three times a day, 2 mg
each time through oral intake, but astagalus was given additionally to the
patients in the treated group once a day via intravenous dripping. All were
treated for 15 days as one therapeutic course and the whole medication lasted
for more than 4 months totally, with follow-up adopted. Astragalus injection
could promote the recovery of hemopoietic function, which might be through
improving T-lymphocyte subsets and reducing the release of negative regulatory
factors such as TNF-alpha and IL-2 to alleviate the inhibition on hemopoietic
function.
Blood sugar
Hypoglycemic effect of polysaccharide enriched extract of Astragalus
membranaceus in diet induced insulin resistant C57BL/6J mice and its potential
mechanism.
Phytomedicine. 2009 Feb 5. Department of Pathophysiology, Medical College of
Wuhan University, Hubei Provincial Key Laboratory of Allergy and Immune-Related
Diseases, 115# Donghu Road, Wuhan 430071, China.
Astragalus polysaccharide exerts insulin-sensitizing and hypoglycemic activities
in type 2 diabetic rats. The present study was designed to confirm the
hypoglycemic effect of Astragalus polysaccharide and to investigate its possible
mechanism underlying the improvement of insulin resistance in vivo and in vitro.
We found Astragalus polysaccharide could alleviate insulin resistance induced by
high glucose. The hyperglycemia, hypolipemia, and hyperinsulinemia status were
controlled with Astragalus polysaccharide therapy. Insulin action in the liver
of insulin resistant mice was restored significantly with Astragalus
polysaccharide administration. The anti-obesity effect and hypolipidemia effects
of Astragalus polysaccharide were probably due partly to decreasing the leptin
resistance of mice, which would positively couple with the normalization of
plasma insulin levels. We have shown that Astragalus polysaccharide has
beneficial effects on insulin resistance and hyperglycemia.
Cancer and use with chemotherapy drugs
Astragalus membranaceus has been used to ameliorate the side effects of anti-neoplastic
drugs.
Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured
neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus
on daunorubicin cardiotoxicity.
Phytother Res. 2009 Jan 26. Shanghai Institute of Hematology, School of
Medicine, Shanghai Jiao Tong University, Shanghai 20001, China.
Anthracyclines are antitumor antibiotics with significant activity against solid
and hematologic malignancies. One problem preventing more widespread use has
been the development of cardiotoxicity. To determine whether antioxidant agents
can reduce the cardiotoxicity of anthracyclines, Astragalus membranaceus was
introduced. Pre-treatment with Astragalus membranaceus significantly attenuated
the daunorubicin-induced increases of reactive oxygen species, apoptosis and the
secretions of LDH in cultured neonatal cardiomyocytes. Compared with Astragalus
membranaceus, N-acetyl-l-cysteine had similar effects on daunorubicin-induced
cell injury. Our results suggested that Astragalus membranaceus is potentially
protective against daunorubicin cardiotoxicity by decreasing free radical
release and apoptosis in cultured neonatal cardiomyocytes.
I would like to
use astragalus herb together with graviola herb for cancer treatment, are there
any studies that have combined the two products?
We are not aware of studies that have combined graviola herb
along with this immune herb.
Fatigue
Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome
induced by food intake restriction plus forced swimming.
J Ethnopharmacol. 2009 Feb 25; National Research Institute of Chinese Medicine,
Taipei, Taiwan, ROC.
Alteration of immune function may be associated with chronic fatigue syndrome (CFS)
and this study reveals the immunoregulatory effect of Astragalus membranaceus
flavonoids. Rats were induced by food intake restriction plus forced swimming
for 6 weeks. An atrophied spleen associated with a significantly decreased
spleen/body weight ratio and a reduced spleen cells proliferation was found in
these rats when compared with home cage controls. Astragalus membranaceus
flavonoids given orally at 20, 50 and 100mg/kg body weight once a day
consecutively for 6 weeks recovered the reduced cell proliferation. A switch to
Th1-dominated immune regulation was observed in these rats as the cultured
splenocytes produced more interleukin-2 (IL-2) but less IL-4 when compared with
controls. Supplementation with Astragalus membranaceus flavonoids counteracted
the aberrant cytokine production and rats receiving Astragalus membranaceus
flavonoids exhibited higher endurance capacity to swim when compared with those
without the herb. Alterations of immune function may be associated with CFS and
the tonic effects of Astragalus membranaceus flavonoids against CF may be
attributable to balance the abnormal cytokine level by isoflavones.
Heart failure
Astragalus has protective effect on heart tissue and may be helpful in congestive heart failure.
Study on effect of Astragalus injection in treating congestive heart failure.
Zhou ZL,
Yu P.Third People's Hospital, Hangzhou 310009.
To observe the clinical efficacy and side-effects of Astragalus
Injection in treating congestive heart failure (CHF). Eighty-three CHF patients with heart function of II-IV grade assessed by New York
Heart Association classification were randomly divided into 2 groups. The 42
patients in the treated group were treated with astragalus 40 ml (equivalent to 80 g
crude drug) by adding in 5% glucose solution 500 ml for intravenous dripping,
once a day and the 41 patients in the control group were treated by nitrolingual
injection. The therapeutic course in both groups was 2 weeks and
the patients were followed-up for 1- 6 months. The clinical heart
function improvement rate and the total effective rate in the astragalus treated
group after 1 month treatment were 26% and 78%, and after 6 months
were 34% and 81% respectively, which were superior to those in the
control group significantly. The levels of left ventricular ejection
fraction, fractional shortening of left ventricular short axis, stroke volume,
cardiac output and the cardiac index were all improved in both groups, but better improvement was shown in the astragalus group.
Follow-up study showed that the incidence of cardiac event was lower in the
astragalus group than that in the control group. Astragalus can be
viewed as one of the important auxiliary drugs for treatment of CHF especially in
severe cases.
Immune system
Astragalus improves certain parts of the immune system, and
may have some anti-HIV activity. It's not clear whether astragalus would have anti-HIV activity when ingested as a
supplement.
Astragalus and kidney
disease
Astragalus may be helpful in diabetic nephropathy. This herb may also act as a
diuretic.
Protective effects of Astragalus saponin I on early stage of diabetic
nephropathy in rats.
J Pharmacol Sci. 2004 Jun;95(2):256-66.
Diabetic nephropathy (DN) has become the leading cause of end stage
failure, but no renoprotective treatment has been very available for use
in DN. Astragalus saponin I, a component extracted from Astragalus
membranaceus, was studied in experimental DN induced by
administration of streptozotocin in male rats. The early DN rats were
treated with 3 doses of astragalus for 8 weeks to analyze its efficacy
with different parameters. By comparison with vehicle-treated DN rats, the
renal hypertrophy, the oxidative stress intensity, and the blood glucose
level of DN rats were ameliorated by astragalus. Also, the
microalbuminuria level, advanced glycated end-products either in serum or
in kidney cortex, and the aldose reductase activity were significantly
reduced. The
results suggest that astragalus has therapeutic effects on several
pharmacological targets in the progress of DN and is a potential drug for
prevention of early stage DN.
Aqueous
extract of Astragali Radix induces human natriuresis through enhancement
of renal response to atrial natriuretic peptide.
J Ethnopharmacol. 2008 Mar 28; Department of Nephrology & Rheumatology,
Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072,
China.
The diuretic effect of astragalus root in humans was described in
ancient books, but its mechanism has not been identified. To evaluate
its diuretic / natriuretic effect, we conducted a double-blind,
randomized, crossover study in 12 healthy men. They were randomized to
receive either placebo or a single oral dosage of 0.3g/kg body weight of
aqueous extract of astragalus root. Compared with placebo, astragalus
root treatment markedly increased urinary sodium excretion, fractional
sodium excretion, and urinary excretion of chloride during the first 4h.
No significant changes of these parameters were observed during 12h or
24h. We show here that astragalus root induces a marked natriuresis in
healthy men, which is attributed to enhanced renal responses to
endogenous A-type Natriuretic Peptide. The Astragaloside IV in the
astragalus root is not the active component for natriuresis.
Effect of
Astragalus membranaceus and Angelica sinensis combined with Enalapril in
rats with obstructive uropathy.
Phytother Res. 2009 Dec 3. Wojcikowski K, Wohlmuth H, Johnson DW, Gobe
G. Molecular and Cellular Pathology, School of Medicine, University of
Queensland, Brisbane, Queensland, Australia.
ACE inhibitors (ACEi) reduce renal tubulointerstitial fibrosis but are
not completely effective. Combined extract of Astragalus membranaceus
and Angelica sinensis (A&A) is a traditional antifibrotic agent in
China. The present investigation aimed to determine whether an ACEi (Enalapril)
and A&A together have a better antifibrotic effect in unilateral
ureteral obstruction (UUO) than monotherapy with either agent. Male
Sprague-Dawley rats (N = 4 per group) had either sham operation or UUO
alone, with A&A (combined aqueous and ethanol extract equivalent to 2.1
g dried herbs), with Enalapril (in drinking water at 200 mg/mL) or with
both treatments. Kidney and liver were collected for protein extraction
or fixed for histologic stains, immunohistochemistry (IHC), microscopy.
Enalapril or A&A individually were antifibrotic. Transforming growth
factor-beta1, fibroblast activation, collagen deposition, macrophage
accumulation and tubular cell apoptosis were all decreased. The
combination of the two drugs was significantly more effective than
Enalapril alone in reducing tumor necrosis factor-alpha, collagen
accumulation, activation of fibroblasts, and tubular cell apoptosis. In
conclusion, Enalapril with A&A significantly decreased
tubulointerstitial fibrosis to a greater extent than treatment with
Enalapril alone.
Skin and melanin
Inhibitory effects of calycosin isolated from the root of Astragalus
membranaceus on melanin biosynthesis.
Biol Pharm Bull. 2009 Feb; Korea Research Institute of Bioscience and
Biotechnology, Daejeon, Korea.
Tyrosinase is a key enzyme for melanin biosynthesis, and
hyperpigmentation disorders are associated with abnormal accumulation of
melanin pigments, which can be reduced by treatment with depigmenting
agents. A methanol extract of Astragalus membranaceus showed inhibitory
activity against mushroom tyrosinase. The active compound was purified
from the methanol extract of Astragalus membranaceus and, following
several chromatographic methods, was identified as calycosin. The
results showed that calycosin exhibited tyrosinase inhibitory activity.
Calycosin showed a melanin biosynthesis inhibition zone in a culture
plate of Streptomyces bikiniensis, which is commonly used as an
indicator organism. Furthermore, calycosin dramatically reduced melanin
synthesis of Melan-a cells without any apparent cytotoxicity and reduced
expression of melanogenic enzyme, tyrosinase. These results suggest that
calycosin may be an effective skin-lightening agent that regulates the
expression of melanogenic enzymes.
Astragalus root supplement side effects
and safety
No major side effect have been reported in humans as of April 2010.